Cordis' Adroit Guiding Catheter Cleared in US and Europe

August 9, 2013—Cordis Corporation (Bridgewater, NJ) recently announced regulatory approval for the Adroit 6-F guiding catheter, which is intended for use for a wide range of challenging cases, including complex lesions and those to be conducted using the radial approach. On June 12, the company advised that the device received US Food and Drug Administration (FDA) clearance to be marketed in the United States. On May 17, it received CE Mark approval in Europe.

According to the company, the Adroit catheter features a .072-inch diameter with an innovative hybrid braid wire technology that facilitates better control and back-up support. The design incorporates a flexible distal segment and soft longer tip that allows atraumatic placement and stability. The Adroit guiding catheter provides a wide range of shapes, including extra back-up shapes and radial-specific shapes to support the treatment needs of various coronary anatomies.